10.1093/brain/awaa238 190 HorsagerJ.KnudsenK.BorghammerP
Advanced nutraceutical approaches to parkinsons disease: bridging nutrition and neuroprotection
The proposal is straightforward: Move toward biomarker-driven patient stratification Design more flexible, biology-informed clinical trials Align regulatory approaches with what already works in oncology and dementia Dementia offers a useful reference point
About 7%-12% percent of North American, European, and Australian people have this mutation
Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature
Behind these questions, however, lurks a smorgasbord of others relating to BPC-157 itself, a compound which, most likely, few runners had even heard of until it suddenly hit the news